A Non-Profit Approach to Address Foreign Dependence of Generic Drugs.
J Law Med Ethics
; 49(1): 30-33, 2021.
Article
in English
| MEDLINE | ID: covidwho-1221085
ABSTRACT
The COVID-19 pandemic has revealed the vulnerability of the US generic drug supply chain to foreign production. Many policies have been proposed to mitigate this vulnerability. In this article, we argue that nonprofit drug manufacturers have the potential to make important contributions.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Organizations, Nonprofit
/
Drugs, Generic
/
Drug Industry
/
Prescription Drugs
Country/Region as subject:
North America
Language:
English
Journal:
J Law Med Ethics
Journal subject:
Nursing
/
Ethics
/
Jurisprudence
/
Medicine
/
Health Services Research
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS